Skip to content
Government Federal, Medical Health Aged Care

Safe access to contraception must be a priority

Pharmaceutical Society of Australia (PSA) 2 mins read

26 May 2023

A Senate Committee report into sexual and reproductive healthcare has supported the Pharmaceutical Society of Australia’s (PSA’s) call for pharmacists to play a greater role in improving safe access to contraceptives.

The Report tabled by the Senate Community Affairs Reference Committee, Ending the postcode lottery: Addressing barriers to sexual, maternity and reproductive healthcare in Australia, recommended significant changes to Australia's health system to make contraception, abortion and pregnancy care more accessible.

Among the recommendations are calls for all health professionals to practise to their full scope.

PSA National President Dr Fei Sim FPS acknowledged the recommendations, reiterating her support for pharmacist-prescribed contraceptives.

“Safe access to latest and safest contraception is not a luxury, it is a basic healthcare need,” Dr Sim said.

“Pharmacists are ready and able to improve healthcare for all Australians, offering safe, accessible, and equitable access to contraception and expert advice on their options.

“In many places around the world, pharmacists are already able to prescribe contraceptives to patients, giving us a model of care that is improving healthcare access for patients.

“To ensure that access to reproductive healthcare is timely and contemporary we must be prepared to do things differently and allow all health professionals to practice to their top of scope.

“Oral contraceptive pills are widely considered to be safe and effective medications, with more than 100 countries around the world allowing pharmacists to prescribe them without a prescription.

“Pharmacists are well placed to inform patients about their contraceptive options, including Long Acting Reversible Contraceptives.

“This is about making sure that Australians can access contraception when and where they need it.

“Pharmacists can and should be doing more to support the healthcare needs of Australians,” Dr Sim concluded. 


About us:

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

 


Contact details:

Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

 

More from this category

  • Medical Health Aged Care
  • 26/10/2024
  • 01:10
Rigaku Holdings Corporation

Listing on the Tokyo Stock Exchange Prime Market

TOKYO--BUSINESS WIRE-- Rigaku Holdings Corporation, a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; "Rigaku"), has completed its listing on the Tokyo Stock Exchange Prime Market as of today. Note: This document is a press release intended for public announcement regarding Rigaku's listing on the Tokyo Stock Exchange Prime Market. It has not been prepared for the purpose of soliciting investments or any similar acts, whether within or outside Japan. This press release does not constitute an offer or sale of securities in the United States. The shares of common stock of Rigaku may…

  • Medical Health Aged Care
  • 25/10/2024
  • 16:11
Galderma

Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends

Galderma convenes a new edition of the Galderma Aesthetic Injector Network (GAIN) event in the Asia-Pacific region (JPAC), which will be the largest to…

  • Contains:
  • Government Federal, Medical Health Aged Care
  • 25/10/2024
  • 11:30
House of Representatives

Alcohol and other drug health hearings begin

The House of RepresentativesStanding Committee on Health, Aged Care and Sportwill convene a series of public hearings next week in support of itsinquiry into the health impacts of alcohol and other drugs in Australia. The hearings will be held in Melbourne on 28 and 29 October, and in Brisbane on 30 October 2024. Committee Chair,Dr Mike Freelander MP, said that the inquiry had attracted significant public interest since commencing in August. ‘The Committee has received a large number of written submissions highlighting several crucial issues, including the stigma preventing early intervention, links between substance use and domestic violence, and opportunities…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.